Anne Regelin
Papers
1
Total Citations
10
H-Index
1
About
Anne Regelin’s research lies at the intersection of drug delivery and molecular biology, with a particular focus on developing innovative methods for non-viral gene therapy. Her most cited work, “High Throughput Screening Method for Identification of New Lipofection Reagents” (2001), introduced a groundbreaking approach to rapidly identify and optimize lipofection reagents—synthetic carriers that deliver genetic material into cells. This method streamlined the discovery of more efficient and less toxic transfection agents, addressing a critical bottleneck in gene therapy and biomedical research. With 10 citations, this paper has served as a foundational reference for scientists seeking to enhance lipid-based delivery systems. Regelin’s contributions have advanced the understanding of how to design and screen reagents for improved cellular uptake and gene expression, impacting fields from basic cell biology to therapeutic development. Her work exemplifies the power of high-throughput strategies in accelerating the translation of laboratory discoveries into clinical applications, making her a notable figure in the ongoing quest for safer and more effective gene therapies.
Research Focus
Key Achievements
Top Papers
- 1